Thrombosis and Haemostasis · 2009 · 44 citations · 33 references
Veterinary MedicineBiochemistryCardiologyImmunopathologyInflammationProteomicsCardiac BiomarkersCardiovascular DiseaseCoagulation AbnormalitiesEndothelial DysfunctionHeart FailurePlasma ProteinsB-type Natriuretic PeptidesEndothelial Activation MarkersLeft Ventricular Ejection Fraction DeclineLeft Ventricular FailureLeft Ventricular Systolic FunctionVon Willebrand Factor Activity AssaysVon Willebrand Factor AntigenVon Willebrand Factor Function
Decreased activity of ADAMTS13, the von Willebrand factor (VWF) cleaving protease, was recently reported in cardiovascular diseases and in hepatic failure. Chronic heart failure (CHF) is characterised by abnormalities of left ventricular function accompanied by the failure of the liver and dysregulation of endothelial activation. Therefore, the aim of our study was to measure ADAMTS13 activity in CHF, and determine the prognostic value of VWF and ADAMTS13 on major clinical events in CHF. ADAMTS13 activity (measured by FRETS-VWF73 substrate) was decreased in CHF (n = 152, left ventricular ejection fraction <45%), and it correlated negatively with B-type natriuretic peptide (BNP) NYHA (New York Heart Association) classes, markers of synthetic capacity of the liver and endothelial dysfunction (all p < 0.005). Both, high VWF:Ag levels (hazard ratio [HR] 1.52, 95% confidence interval [CI] 1.189-1.943), and low ADAMTS13/VWF:Ag ratios (HR 0.70, 95% CI 0.58-0.84) independently and significantly predicted short-term (1 year follow-up) clinical adverse events in heart failure (HF). Decreased activity of ADAMTS13 with concomitant high VWF:Ag levels is a significant independent predictor of clinical events in CHF. The levels of the two molecules may integrate the impaired synthetic capacity of the liver and the disturbed endothelial regulation and can therefore be a useful tool to predict clinical events in CHF.
33
Changes in health and disease of the metalloprotease that cleaves von Willebrand factor
Pier Mannuccio Mannucci, Maria Teresa Canciani, Ileana Forza et al. · Blood · 2001 · 507 citations · Full text
Andrew Farb, Anita L. Tang, Allen Burke et al. · Circulation · 1995 · 417 citations
Tomoko Ono, Jun Mimuro, Seiji Madoiwa et al. · Blood · 2005 · 397 citations